Literature DB >> 23082736

Primary CNS lymphoma: a clinician's guide.

Niklas Schäfer1, Martin Glas, Ulrich Herrlinger.   

Abstract

Primary CNS lymphoma is a high malignant disease of the brain which can lead rapidly to death if diagnosis and/or the start of treatment is delayed. The age at time of diagnosis is a strong factor influencing prognosis so that in younger patients <65 years of age long-term survival may be achieved in a substantial percentage of patients, while in elderly patients long-term survival is seen much more rarely. First-line therapy consists of high-dose methotrexate-based (poly)chemotherapy. This review provides an overview of clinical presentation, steps to diagnosis, detailed information about current treatment concepts and specific information for particular clinical situations.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23082736     DOI: 10.1586/ern.12.120

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  9 in total

1.  Predictive value of microRNAs as novel biomarkers in detection of lymphoma.

Authors:  Yongjing Wang; Dianshui Sun; Juandong Wang; Aixia Dou; Chengyun Zheng
Journal:  Int J Clin Exp Med       Date:  2015-08-15

Review 2.  What is known and unknown about chemotherapy-related cognitive impairment in patients with haematological malignancies and areas of needed research.

Authors:  Annalynn M Williams; Clive S Zent; Michelle C Janelsins
Journal:  Br J Haematol       Date:  2016-07-08       Impact factor: 6.998

3.  Serum miR-21 is a diagnostic and prognostic marker of primary central nervous system lymphoma.

Authors:  Xuhua Mao; Yuan Sun; Junming Tang
Journal:  Neurol Sci       Date:  2013-07-06       Impact factor: 3.307

4.  Identification of miRNAs as potential new biomarkers for nervous system cancer.

Authors:  Yong Wang; Jinchuan Liang; Cuili Di; Guiliang Zhao; Yaqun Zhao
Journal:  Tumour Biol       Date:  2014-08-20

5.  Lymphomatosis cerebri mimicking iatrogenic Creutzfeldt-Jakob disease.

Authors:  Elena Rivero Sanz; Miguel Ángel Torralba Cabeza; Francisco Sanjuán Portugal; Federico García-Bragado
Journal:  BMJ Case Rep       Date:  2014-09-08

6.  MicroRNAs as Potential Biomarkers for Diagnosing Cancers of Central Nervous System: a Meta-analysis.

Authors:  Dong Wei; Qun Wan; Li Li; Haifeng Jin; Yonghong Liu; Yangang Wang; Guangyun Zhang
Journal:  Mol Neurobiol       Date:  2014-08-01       Impact factor: 5.590

7.  Primary central nervous system lymphoma mimicking recurrent depressive disorder: A case report.

Authors:  Weibo Liu; Jing Xue; Shaohua Yu; Qiaozhen Chen; Xiuzhen Li; Risheng Yu
Journal:  Oncol Lett       Date:  2015-02-13       Impact factor: 2.967

8.  Hyperosmolar and methotrexate therapy avoiding surgery in the acute presentation of primary central nervous system lymphoma.

Authors:  Bryan S Lee; Rupa G Juthani; Andrew T Healy; David M Peereboom; Violette M Recinos
Journal:  Surg Neurol Int       Date:  2014-07-16

9.  Radiotherapy as an alternative treatment option for primary central nervous system lymphoma patients who are noncandidates for chemotherapy.

Authors:  Yoo-Kang Kwak; Byung-Ock Choi; Kyu Hye Choi; Jong Hoon Lee; Soo Yoon Sung; Yun Hee Lee
Journal:  Oncotarget       Date:  2017-11-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.